Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease.
J Nat Med
; 77(1): 73-86, 2023 Jan.
Article
in En
| MEDLINE
| ID: mdl-36115008
Full text:
1
Database:
MEDLINE
Main subject:
Non-alcoholic Fatty Liver Disease
Language:
En
Journal:
J Nat Med
Year:
2023
Type:
Article
Affiliation country:
China